Irinotecan Hydrochloride Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Irinotecan Hydrochloride Injection (injection) from Teva Pharmaceuticals USA, Inc. with status No longer listed by FDA. The shortage was first posted on Aug 4, 2025.
Shortage details
- Status
- No longer listed by FDA
- Company
- Teva Pharmaceuticals USA, Inc.
- Package NDC
- 45963-614-51
- Dosage Form
- Injection
- Presentation
- Irinotecan Hydrochloride, Injection, 20 mg/1 mL (NDC 45963-614-51)
- Initial Posting
- Aug 4, 2025